• Explore /
  • Poster
  • / Predictive biomarkers of sensitivity to androgen receptor signaling (ARS) and taxane-based chemotherapy in circulating tumor cells (CTCs) of patients (pts) with metastatic castration resistant prostate cancer (mCRPC).

Predictive biomarkers of sensitivity to androgen receptor signaling (ARS) and taxane-based chemotherapy in circulating tumor cells (CTCs) of patients (pts) with metastatic castration resistant prostate cancer (mCRPC).

Abstract Poster

Authors

null

Howard I. Scher

Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY

Howard I. Scher , Jessica Louw , Adam Jendrisak , Richard Martin Bambury , Daniel Costin Danila , Dana E. Rathkopf , Zaina Arslan , Nicole A. Schreiber , David Lu , Rachel Krupa , Dena Marrinucci , Mark Landers , Ryan Vance Dittamore

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Prostate Cancer

Track

Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 33, 2015 (suppl 7; abstr 147)

DOI

10.1200/jco.2015.33.7_suppl.147

Abstract #

147

Poster Bd #

G9

Abstract Disclosures

Similar Posters

First Author: Richard Cathomas

First Author: Dana E. Rathkopf

First Author: Karim Fizazi

Poster

2019 Genitourinary Cancers Symposium

Whole blood FOLH1 mRNA expression and treatment response in metastatic castration-resistant prostate cancer (mCRPC).

Whole blood FOLH1 mRNA expression and treatment response in metastatic castration-resistant prostate cancer (mCRPC).

First Author: Edmond Michael Kwan